Cargando…
Bispecific antibodies: A guide to model informed drug discovery and development
Affinity (KD) optimization of monoclonal antibodies is one of the factors that impacts the stoichiometric binding and the corresponding efficacy of a drug. This impacts the dose and the dosing regimen, making the optimum KD a critical component of drug discovery and development. Its importance is fu...
Autores principales: | Kareva, Irina, Zutshi, Anup, Gupta, Pawan, Kabilan, Senthil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8334385/ https://www.ncbi.nlm.nih.gov/pubmed/34381902 http://dx.doi.org/10.1016/j.heliyon.2021.e07649 |
Ejemplares similares
-
Mathematical modeling of SARS-CoV-2 viral dynamics and treatment with monoclonal antibodies
por: Kareva, Irina, et al.
Publicado: (2022) -
Identifying Safety Thresholds for Immunosuppressive Drugs: Applying Insights from Primary Antibody Deficiencies to Mitigate Adverse Events in Secondary Antibody Deficiencies Using Mathematical Modeling of Preclinical and Early Clinical Data
por: Kareva, Irina, et al.
Publicado: (2021) -
Correction to: Identifying Safety Thresholds for Immunosuppressive Drugs: Applying Insights from Primary Antibody Deficiencies to Mitigate Adverse Events in Secondary Antibody Deficiencies Using Mathematical Modeling of Preclinical and Early Clinical Data
por: Kareva, Irina, et al.
Publicado: (2021) -
A high throughput bispecific antibody discovery pipeline
por: Segaliny, Aude I., et al.
Publicado: (2023) -
Guiding model‐driven combination dose selection using multi‐objective synergy optimization
por: Gevertz, Jana L., et al.
Publicado: (2023)